CRIS Current Research Information System

VAIRA, BERARDINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.199
NA - Nord America 9.930
AS - Asia 9.360
SA - Sud America 996
AF - Africa 346
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 11
Totale 33.862
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.813
IT - Italia 7.486
SG - Singapore 3.501
CN - Cina 2.313
VN - Vietnam 1.611
GB - Regno Unito 1.536
HK - Hong Kong 970
DE - Germania 836
BR - Brasile 797
SE - Svezia 658
NL - Olanda 561
UA - Ucraina 435
RU - Federazione Russa 418
IN - India 368
FR - Francia 300
IE - Irlanda 239
ZA - Sudafrica 150
KR - Corea 144
JP - Giappone 124
BG - Bulgaria 119
FI - Finlandia 113
EE - Estonia 112
CH - Svizzera 110
JO - Giordania 92
AR - Argentina 85
ES - Italia 66
SC - Seychelles 65
ID - Indonesia 61
CA - Canada 56
CI - Costa d'Avorio 50
AT - Austria 40
MX - Messico 40
BE - Belgio 34
PL - Polonia 34
BD - Bangladesh 33
EC - Ecuador 31
TG - Togo 27
PY - Paraguay 23
AL - Albania 22
TR - Turchia 22
GR - Grecia 18
CO - Colombia 16
EU - Europa 16
PE - Perù 15
RO - Romania 15
MY - Malesia 13
EG - Egitto 12
LB - Libano 12
PK - Pakistan 12
IQ - Iraq 11
LT - Lituania 11
CL - Cile 10
DO - Repubblica Dominicana 10
IR - Iran 9
MA - Marocco 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
LY - Libia 8
AU - Australia 7
IL - Israele 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
TH - Thailandia 6
HR - Croazia 5
KE - Kenya 5
KZ - Kazakistan 5
PH - Filippine 5
PT - Portogallo 5
NG - Nigeria 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
LU - Lussemburgo 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
HU - Ungheria 2
MT - Malta 2
NO - Norvegia 2
SM - San Marino 2
SR - Suriname 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CV - Capo Verde 1
GL - Groenlandia 1
GY - Guiana 1
Totale 33.842
Salva come PNG Salva come JPEG
Città #
Singapore 1.991
Southend 1.352
Hong Kong 962
Ashburn 908
Santa Clara 883
Fairfield 814
Milan 752
Chandler 673
Rome 552
Boardman 543
Woodbridge 416
Hefei 402
Wilmington 400
Seattle 379
Ho Chi Minh City 373
Princeton 367
Bologna 353
Houston 353
Beijing 324
Jacksonville 289
Naples 284
Cambridge 283
Hanoi 276
Ann Arbor 249
Dong Ket 246
Dublin 239
Padova 179
Turin 165
Nanjing 155
Westminster 149
Los Angeles 141
Seoul 139
Bari 128
Tokyo 120
Sofia 119
Florence 114
Berlin 113
New York 111
Buffalo 103
Amman 92
Helsinki 90
Palermo 84
Jinan 78
Verona 71
São Paulo 70
Saint Petersburg 69
Shenyang 66
Catania 65
Redondo Beach 60
Tappahannock 60
San Diego 58
Mülheim 57
Brescia 56
Guangzhou 55
Nanchang 55
Shanghai 54
Parma 51
Abidjan 50
Frattamaggiore 50
Genoa 48
Chicago 47
Changsha 45
Tianjin 43
Redmond 41
Da Nang 40
Dallas 40
Zhengzhou 39
Falkenstein 38
Haiphong 38
Modena 38
Reggio Emilia 37
Hebei 36
Trieste 36
Yubileyny 35
Frankfurt am Main 34
Dearborn 33
Mahé 33
Des Moines 32
Bengaluru 30
Hangzhou 30
Brussels 29
Nuremberg 29
Biên Hòa 28
Boydton 28
Hải Dương 28
Pescara 28
Rio de Janeiro 28
Cagliari 27
Lomé 27
Medford 27
Livorno 25
Venice 25
Salamanca 24
Bergamo 23
Jakarta 23
Lucca 23
Mexico City 22
Mountain View 22
Thái Nguyên 22
Warsaw 22
Totale 18.993
Salva come PNG Salva come JPEG
Nome #
Helicobacter pylori. Benedetto il giorno che ti ho incontrato 5.463
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale. 969
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 509
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 340
Attuali criteri di terapia dell’infezione da Helicobacter pylori. New treatment of Helicobacter pylori infection 267
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 249
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 227
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 207
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 197
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial 190
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibility 189
Cross-sectional study: CagA-positive helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide 184
H. pylori antibiotic resistance and 13C urea breath test values. 183
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 178
Response to Dr Osato and Graham 177
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 174
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 174
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 174
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance. 173
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 172
13C-urea breath test values and Helicobacter pylori eradication 170
Effects of Helicobacter pylori eradication on early-stage gastric mucosa associated lymphoid tissue lymphoma. 169
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 166
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 163
E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply 161
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 161
Gastroesophageal Reflux Disease and Barrett’s Esophagus 159
Diagnosi dell’infezione da Helicobacter pylori 157
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 156
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 154
Treatment of Helciobacter pylori infection 2014 153
Test rapido per la determinazione della chemiosensibilità dell'Helicobacter pylori 153
A human domain antibody and Lewisb–glyconjugate that inhibit binding of Helicobacter pylori to Lewisb receptor and inhibit bacterial adhesion to human gastric epithelium 153
Phenotypic and genotype H. pylori Clarithromycin resistance and therapeutic outcomes: benefit and limits. 153
The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori 153
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 153
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 149
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 149
Therapy for H. pylori: Current concepts 147
How useful is the rapid urease test for evaluating the success of Helicobacter pylori eradication therapy? 146
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 146
In vivo dissolution of levothyroxine soft gel capsules 145
Diagnosi non invasiva e terapia per Helicobacter Pylori 144
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial 143
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease 143
Nuove terapie per curare l’infezione da Helicobacter pylori 142
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 139
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 138
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 137
Peptic ulcer and Helicobacter pylori. 136
Helicobacter pylori and functional dyspepsia: an unsolved issue? 135
An Atlas of Investigation and Management: HELICOBACTER PYLORI 135
Management of helicobacter pylori infection-the Maastricht V/Florence consensus report 135
Serological markers for gastric atrophy in asymptomatic subjects infected with Helicobacter pylori. 134
A combination of faecal tests for the detection of colon cancer: a new strategy for appropriate selection of referrals to colonoscopy ? A prospective multicenter italian study. 134
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 133
Growth and adult height in atypical coeliac patients, with or without growth hormone deficiency. 133
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 133
Are Helicobacter Species and Enterotoxigenic Bacteroides fragilis Involved in Inflammatory Bowel Disease? 132
The prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid nineties: an 18-yr longitudinal study based on anti-endomysial antibodies 132
Helicobacter pylori: current status and future prospects 131
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 130
Diagnosis of Helicobacter pylori: invasive and non- invasive tests 130
Diagnosi dell'infezione da Helicobacter pylori 129
Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori 128
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis 127
Twice daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomised controlled trial using standard and double doses of omeprazole within a triple therapy 125
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 124
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 122
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 121
Considerable use of furazolidone in Iran. 121
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 121
Letter: years of life that could be saved by preventing HCC 121
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 120
Global eradication rates for helicobacter pylori infection: systematic review and meta-analysis of sequantial therapy 120
Colonization by Helicobacter pylori of leprosy patients in Spain: immunomodulation to low molecular weight antigens of H pylori 120
Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for Clarithromycin resistance in Helicobacter pylori. 119
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 119
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 118
The A2143G point mutation of Clarithromycin resistance affects H. pylori eradication 118
Sequential therapy for H pylori eradication: is Levofloxacin better? 118
Efficacy of 5-ASA in the treatment of colonic diverticular disease. 118
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori 118
Glaucoma and Helicobacter pylori: Eyes wide shut? 118
Probiotici ricombinanti e loro potenziale sulla salute umana 117
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 117
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 116
Comparison of image analysis software packages in the assessment af adhesion of microorganism of mucosal epithelium using confocal laser scanning microscopy 116
Treatment of Helicobacter Pylori in Latin America 116
Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic patients 116
Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics 116
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 114
Recombinant probiotics and their potential in human health 114
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 114
The sequential therapy regimen for Helicobacter pylori eradication. 113
Stool test for Helicobacter pylori 113
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children 113
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 113
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 112
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 111
Totale 21.037
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.877
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.138 0 0 0 0 0 92 43 120 142 117 99 525
2021/20222.935 308 81 181 295 292 137 60 219 91 92 706 473
2022/20233.143 317 376 185 343 170 237 129 184 588 143 316 155
2023/20243.401 482 336 191 291 187 292 170 130 145 361 429 387
2024/20259.979 555 1.065 607 672 1.984 694 963 631 496 541 355 1.416
2025/20267.870 1.439 1.204 1.532 1.254 1.639 802 0 0 0 0 0 0
Totale 34.546